Below are the available bulk discount rates for each individual item when you purchase a certain amount
|Buy 5 - 24||and pay only $144.00 each|
|Buy 25 - 99||and pay only $142.00 each|
|Buy 100 or above||and pay only $139.99 each|
There are 6 total kits included, 12 tests in total.
1) How long should people wait between taking BinaxNOW Self Tests?
The BinaxNOW COVID-19 antigen self-tests should be administered twice over three days with at least 36 hours between each antigen test.
2) How do I know if I have a positive or negative test?
In order to check for a positive result, you will need to look at the result window for two pink (or purple) lines. Even a faint line next to the word "sample" on the BinaxNOW COVID-19 test card is a positive result. A negative result will only have one pink or purple line on the top half of the COVID-19 test results window where it says "control".
3) What do I do if my BinaxNow Covid-19 antigen self-test result is invalid?
If your BinaxNow antigen test results window has any of the following, the test result may be invalid:
If any of the above BinaxNow COVID-19 test issues arise with your antigen test, please contact: firstname.lastname@example.org to help or answer any further questions.
4) Who should use this COVID-19 self-test?
The BinaxNow COVID-19 antigen self-test for over-the-counter use at home is indicated for all people aged 15 years or older and for children as young as 2 years old when the test samples are collected by an adult. This COVID-19 test can be used for people with and without symptoms.
5) How accurate is Abbott's BinaxNOW COVID-19 test?
According to studies, Abbott’s BinaxNOW COVID-19 antigen self-test has an accuracy rate of 84.6% for detecting covid-19 infections, and 98.5% for correctly identifying covid-19 negatives.
6) What are COVID-19 antigen tests?
COVID-19 Antigen tests are commonly used in the diagnosis of respiratory pathogens, including influenza viruses and respiratory syncytial virus. The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for antigen tests that can identify SARS-CoV-2 (commonly known as COVID-19).